Isolyte S pH 7.4 is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by B. Braun Medical Inc.. The primary component is Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Phosphate, Dibasic; Potassium Phosphate, Monobasic.
| Product ID | 0264-7707_5b859583-d20b-423d-97e2-c340d7a56bb8 |
| NDC | 0264-7707 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Isolyte S pH 7.4 |
| Generic Name | Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, Magnesium Chloride, Sodium Phosphate, Dibasic, And Potassium Phosphate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1989-09-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019696 |
| Labeler Name | B. Braun Medical Inc. |
| Substance Name | SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC |
| Active Ingredient Strength | 1 g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1989-09-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019696 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1989-09-29 |
| Marketing Category | NDA |
| Application Number | NDA019696 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1989-09-29 |
| Ingredient | Strength |
|---|---|
| SODIUM CHLORIDE | .53 g/100mL |
| SPL SET ID: | 150437b6-320e-4c69-a434-2a26a1f0b2e4 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |